Physician profile
Ryan D Mattie
NPI 1245615350
$154,450.05
in general payments reported to CMS, 2019-2025
37 companies · $5,651 in 2025
The $5,651 reported for 2025 was more than what 95% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,178 · 2020: $10K · 2021: $14K · 2022: $39K · 2023: $65K · 2024: $14K · 2025: $5,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $56K · Travel and Lodging: $20K · Food and Beverage: $8,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $56,493.01 |
| Travel and Lodging | $19,639.31 |
| Food and Beverage | $8,525.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $133,968.47 | 2019-2025 | Sprint Pns System |
| Abbott Laboratories | $3,522.98 | 2019-2025 | Eterna, Proclaim, Octrode |
| Nevro Corp. | $2,170.87 | 2019-2024 | Senza |
| Medtronic USA, INC. | $2,058.06 | 2019-2020 | |
| Spinal Simplicity, LLC | $1,705.96 | 2022-2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $1,690.12 | 2019-2024 | Intracept, Wavewriter Alpha Prime 16 |
| Vertiflex, INC. | $1,617.10 | 2019 | |
| Si-Bone, INC. | $1,233.07 | 2019-2023 | |
| Biotronik Nro, INC. | $1,072.63 | 2023-2025 | Prospera, Biotronik |
| Stryker Corporation | $989.44 | 2020-2025 | Mild Device Kit, Vertaplex, Spinejack |
| Vertos Medical, INC. | $938.91 | 2019 | |
| Medtronic, INC. | $839.84 | 2021-2024 | Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $677.21 | 2023-2025 | Evoke Scs, Evoke |
| Stimwave Technologies Incorporated | $323.29 | 2019-2020 | |
| Globus Medical, INC. | $280.79 | 2025 | Senza, Vyrsa V1 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $170.06 | 2021-2025 | Nalu Neurostimulation System |
| Abbvie INC. | $161.59 | 2022-2024 | |
| Arteriocyte Medical Systems, INC. | $120.15 | 2021 | |
| Avanos Medical | $117.60 | 2020-2021 | |
| Painteq LLC | $109.45 | 2022-2023 | Painteq |
| Relievant Medsystems, INC. | $93.38 | 2021-2023 | Intracept |
| Gs Solutions, INC. | $92.20 | 2022 | |
| Zyla Life Sciences, INC. | $79.92 | 2020 | |
| Scilex Pharmaceuticals INC. | $63.64 | 2019 | |
| Lilly USA, LLC | $47.99 | 2019 | |
| Merit Medical Systems INC | $37.75 | 2022-2024 | Stabilit System, Star Tumor Ablation System |
| Kaleo, INC. | $36.85 | 2019 | |
| Pfizer INC. | $35.35 | 2019 | |
| Surgalign Spine Technologies, INC. | $28.30 | 2019 | |
| Baxter Healthcare | $27.78 | 2019 | |
| Depuy Synthes Sales INC. | $27.09 | 2019 | |
| Foundation Fusion Solutions, LLC | $25.08 | 2025 | |
| Fidia Pharma USA INC. | $22.32 | 2023 | Triluron, Hymovis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.93 | 2019 | |
| Shionogi INC | $17.22 | 2019 | |
| Sentynl Therapeutics, INC. | $14.22 | 2019 | |
| Collegium Pharmaceutical, INC. | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mattie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.